We strongly advise to harness Integrated Diagnostics analysis to find out if markets are presently mispricing the company. We are able to interpolate and collect twenty-seven available reported financial drivers for Integrated Diagnostics, which can be compared to its competitors. The stock experiences an unexpected downward movement. The market is reacting to new fundamentals. Check odds of Integrated Diagnostics to be traded at 0.4224 in 90 days. Key indicators impacting Integrated Diagnostics' financial strength include:
Understanding current and past Integrated Diagnostics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Integrated Diagnostics' financial statements are interrelated, with each one affecting the others. For example, an increase in Integrated Diagnostics' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Integrated Diagnostics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Integrated Diagnostics Holdings. Check Integrated Diagnostics' Beneish M Score to see the likelihood of Integrated Diagnostics' management manipulating its earnings.
You should never invest in Integrated Diagnostics without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Integrated Stock, because this is throwing your money away. Analyzing the key information contained in Integrated Diagnostics' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Integrated Diagnostics Key Financial Ratios
There are many critical financial ratios that Integrated Diagnostics' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Integrated Diagnostics reports annually and quarterly.
Comparative valuation techniques use various fundamental indicators to help in determining Integrated Diagnostics's current stock value. Our valuation model uses many indicators to compare Integrated Diagnostics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Integrated Diagnostics competition to find correlations between indicators driving Integrated Diagnostics's intrinsic value. More Info.
Integrated Diagnostics Holdings is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about 0.42 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Integrated Diagnostics Holdings is roughly 2.38 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Integrated Diagnostics' earnings, one of the primary drivers of an investment's value.
Integrated Diagnostics Systematic Risk
Integrated Diagnostics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Integrated Diagnostics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Integrated Diagnostics correlated with the market. If Beta is less than 0 Integrated Diagnostics generally moves in the opposite direction as compared to the market. If Integrated Diagnostics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Integrated Diagnostics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Integrated Diagnostics is generally in the same direction as the market. If Beta > 1 Integrated Diagnostics moves generally in the same direction as, but more than the movement of the benchmark.
Integrated Diagnostics Holdings Total Assets Over Time
Integrated Diagnostics December 25, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Integrated Diagnostics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Integrated Diagnostics Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of Integrated Diagnostics Holdings based on widely used predictive technical indicators. In general, we focus on analyzing Integrated Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Integrated Diagnostics's daily price indicators and compare them against related drivers.
When running Integrated Diagnostics' price analysis, check to measure Integrated Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integrated Diagnostics is operating at the current time. Most of Integrated Diagnostics' value examination focuses on studying past and present price action to predict the probability of Integrated Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integrated Diagnostics' price. Additionally, you may evaluate how the addition of Integrated Diagnostics to your portfolios can decrease your overall portfolio volatility.